For patients on ICS monotherapy, ATECTURA® BREEZEHALER® (indacaterol acetate/mometasone furoate inhalation powder) long-acting beta2-agonist (LABA)/inhaled corticosteroid (ICS) (IND/MF) is available in three dierent doses: low, medium and high*.1
How to use the BREEZHALER device
Watch the following video to learn how to use the BREEZHALER.
*ATECTURA BREEZHALER high-dose = IND/MF 150/320 μg (once-daily); ATECTURA BREEZHALER medium-dose = IND/MF 150/160 μg (once-daily); ATECTURA BREEZHALER low-dose = IND/MF 150/80 μg (once-daily).
IND, indacaterol; MF, mometasone furoate; AE, adverse event; SAE, serious adverse event.
Reference
- ATECTURA BREEZEHALER Summary of Product Characteristics.